Search
Elsubrutinib
go.drugbank.com/drugs/DB18850InvestigationalElsubrutinib is under investigation in clinical trial NCT04451772 (A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants … With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State).
Ethyl hydroxybenzoate
go.drugbank.com/drugs/DB13628ApprovedInvestigationalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseFormebolone
go.drugbank.com/drugs/DB01569IllicitInvestigationalFormebolone, a derivative of androstane, is an anabolic androgenic steroid. It is on the list of substances prohibited by the Word Anti-Doping Agency, and is regularly screened for in athletes. … [A14416] Additionally, it has been patented for use in development of novel transdermal delivery systems for enhanced drug delivery.
Romlusevimab
go.drugbank.com/drugs/DB16494InvestigationalRomlusevimab (BRII-198) was under investigation in clinical trials (NCT04479644 and NCT04691180) to treat COVID-19, focusing on its safety, tolerability, and pharmacokinetics.
Categories: Experimental Unapproved Treatments for COVID-19Norepinephrine
go.drugbank.com/drugs/DB00368ApprovedInvestigationalIt is also found in plants and is used pharmacologically as a sympathomimetic. … Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter.
Synonyms: L-noradrenaline, L-NorepinephrineProducts: N-EPI® 1mg/ml Concentrate for Solution for Infusion, N-EPISB-509
go.drugbank.com/drugs/DB05579InvestigationalSB-509 is under investigation in multiple clinical trials for the treatment of Diabetic Neuropathy.
Moxaverine
go.drugbank.com/drugs/DB12251InvestigationalMoxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.
Categories: Drugs for Functional Gastrointestinal DisordersPeptide YY (3-36)
go.drugbank.com/drugs/DB05004InvestigationalPeptide YY (3-36), a synthetic human PYY 3-36, is a compound being evaluated for the treatment of obesity. It reduces appetite and increases satiety in obese patients.
Detomidine
go.drugbank.com/drugs/DB11556InvestigationalVet approvedCurrently, it is only approved by the FDA for use in horses but has been studied for use in other large animals. … Detomidine is an α2-adrenergic agonist that is used as a horse sedative. Normally, it is administered in the salt form, detomidine hydrochloride.